[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pharmaceutical Contract Development and Manufacturing Market Growth (Status and Outlook) 2023-2029

March 2023 | 102 pages | ID: G523306F77B8EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Pharmaceutical Contract Development and Manufacturing Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Development and Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Development and Manufacturing sales for 2023 through 2029. With Pharmaceutical Contract Development and Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Development and Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Development and Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Contract Development and Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Development and Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Development and Manufacturing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Development and Manufacturing.

The global Pharmaceutical Contract Development and Manufacturing market size is projected to grow from US$ 118730 million in 2022 to US$ 186070 million in 2029; it is expected to grow at a CAGR of 6.6% from 2023 to 2029.

United States market for Pharmaceutical Contract Development and Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pharmaceutical Contract Development and Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pharmaceutical Contract Development and Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pharmaceutical Contract Development and Manufacturing players cover Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Development and Manufacturing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Pharmaceutical Manufacturing Services
  • Biologics Manufacturing Services
  • Drug Development Services
Segmentation by application
  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group Ltd
  • Recipharm AB
  • Vetter Pharma International GMBH
  • FAMAR Health Care Services
  • AbbVie Inc.
  • Aenova Group
  • Consort Medical plc
  • Almac Group
  • Siegfried Holding AG
  • Boehringer Ingelheim International GmbH
  • Evonik Industries AG
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pharmaceutical Contract Development and Manufacturing Market Size 2018-2029
  2.1.2 Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical Contract Development and Manufacturing Segment by Type
  2.2.1 Pharmaceutical Manufacturing Services
  2.2.2 Biologics Manufacturing Services
  2.2.3 Drug Development Services
2.3 Pharmaceutical Contract Development and Manufacturing Market Size by Type
  2.3.1 Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical Contract Development and Manufacturing Segment by Application
  2.4.1 Big Pharma
  2.4.2 Small Pharma
  2.4.3 Generic Pharma
  2.4.4 CRO
2.5 Pharmaceutical Contract Development and Manufacturing Market Size by Application
  2.5.1 Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)

3 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET SIZE BY PLAYER

3.1 Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Players
  3.1.1 Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2018-2023)
  3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Contract Development and Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING BY REGIONS

4.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical Contract Development and Manufacturing Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical Contract Development and Manufacturing Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pharmaceutical Contract Development and Manufacturing by Country (2018-2023)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FORECAST

10.1 Global Pharmaceutical Contract Development and Manufacturing Forecast by Regions (2024-2029)
  10.1.1 Global Pharmaceutical Contract Development and Manufacturing Forecast by Regions (2024-2029)
  10.1.2 Americas Pharmaceutical Contract Development and Manufacturing Forecast
  10.1.3 APAC Pharmaceutical Contract Development and Manufacturing Forecast
  10.1.4 Europe Pharmaceutical Contract Development and Manufacturing Forecast
  10.1.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Forecast
10.2 Americas Pharmaceutical Contract Development and Manufacturing Forecast by Country (2024-2029)
  10.2.1 United States Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.2.2 Canada Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.2.3 Mexico Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.2.4 Brazil Pharmaceutical Contract Development and Manufacturing Market Forecast
10.3 APAC Pharmaceutical Contract Development and Manufacturing Forecast by Region (2024-2029)
  10.3.1 China Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.3.2 Japan Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.3.3 Korea Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.3.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.3.5 India Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.3.6 Australia Pharmaceutical Contract Development and Manufacturing Market Forecast
10.4 Europe Pharmaceutical Contract Development and Manufacturing Forecast by Country (2024-2029)
  10.4.1 Germany Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.4.2 France Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.4.3 UK Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.4.4 Italy Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.4.5 Russia Pharmaceutical Contract Development and Manufacturing Market Forecast
10.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Forecast by Region (2024-2029)
  10.5.1 Egypt Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.5.2 South Africa Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.5.3 Israel Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.5.4 Turkey Pharmaceutical Contract Development and Manufacturing Market Forecast
  10.5.5 GCC Countries Pharmaceutical Contract Development and Manufacturing Market Forecast
10.6 Global Pharmaceutical Contract Development and Manufacturing Forecast by Type (2024-2029)
10.7 Global Pharmaceutical Contract Development and Manufacturing Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific Inc.
  11.1.1 Thermo Fisher Scientific Inc. Company Information
  11.1.2 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
  11.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.1.5 Thermo Fisher Scientific Inc. Latest Developments
11.2 Catalent, Inc.
  11.2.1 Catalent, Inc. Company Information
  11.2.2 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
  11.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Catalent, Inc. Main Business Overview
  11.2.5 Catalent, Inc. Latest Developments
11.3 Lonza Group Ltd
  11.3.1 Lonza Group Ltd Company Information
  11.3.2 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Offered
  11.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Lonza Group Ltd Main Business Overview
  11.3.5 Lonza Group Ltd Latest Developments
11.4 Recipharm AB
  11.4.1 Recipharm AB Company Information
  11.4.2 Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Offered
  11.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Recipharm AB Main Business Overview
  11.4.5 Recipharm AB Latest Developments
11.5 Vetter Pharma International GMBH
  11.5.1 Vetter Pharma International GMBH Company Information
  11.5.2 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Offered
  11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Vetter Pharma International GMBH Main Business Overview
  11.5.5 Vetter Pharma International GMBH Latest Developments
11.6 FAMAR Health Care Services
  11.6.1 FAMAR Health Care Services Company Information
  11.6.2 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Offered
  11.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 FAMAR Health Care Services Main Business Overview
  11.6.5 FAMAR Health Care Services Latest Developments
11.7 AbbVie Inc.
  11.7.1 AbbVie Inc. Company Information
  11.7.2 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
  11.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 AbbVie Inc. Main Business Overview
  11.7.5 AbbVie Inc. Latest Developments
11.8 Aenova Group
  11.8.1 Aenova Group Company Information
  11.8.2 Aenova Group Pharmaceutical Contract Development and Manufacturing Product Offered
  11.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Aenova Group Main Business Overview
  11.8.5 Aenova Group Latest Developments
11.9 Consort Medical plc
  11.9.1 Consort Medical plc Company Information
  11.9.2 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Offered
  11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Consort Medical plc Main Business Overview
  11.9.5 Consort Medical plc Latest Developments
11.10 Almac Group
  11.10.1 Almac Group Company Information
  11.10.2 Almac Group Pharmaceutical Contract Development and Manufacturing Product Offered
  11.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Almac Group Main Business Overview
  11.10.5 Almac Group Latest Developments
11.11 Siegfried Holding AG
  11.11.1 Siegfried Holding AG Company Information
  11.11.2 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Offered
  11.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Siegfried Holding AG Main Business Overview
  11.11.5 Siegfried Holding AG Latest Developments
11.12 Boehringer Ingelheim International GmbH
  11.12.1 Boehringer Ingelheim International GmbH Company Information
  11.12.2 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Offered
  11.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Boehringer Ingelheim International GmbH Main Business Overview
  11.12.5 Boehringer Ingelheim International GmbH Latest Developments
11.13 Evonik Industries AG
  11.13.1 Evonik Industries AG Company Information
  11.13.2 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Offered
  11.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Evonik Industries AG Main Business Overview
  11.13.5 Evonik Industries AG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Pharmaceutical Manufacturing Services
Table 3. Major Players of Biologics Manufacturing Services
Table 4. Major Players of Drug Development Services
Table 5. Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Table 8. Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Table 11. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Player (2018-2023)
Table 13. Pharmaceutical Contract Development and Manufacturing Key Players Head office and Products Offered
Table 14. Pharmaceutical Contract Development and Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Regions (2018-2023)
Table 19. Global Pharmaceutical Contract Development and Manufacturing Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Country (2018-2023)
Table 23. Americas Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Table 25. Americas Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Table 27. APAC Pharmaceutical Contract Development and Manufacturing Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Region (2018-2023)
Table 29. APAC Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Table 31. APAC Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Table 33. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Country (2018-2023)
Table 35. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Table 37. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Pharmaceutical Contract Development and Manufacturing
Table 46. Key Market Challenges & Risks of Pharmaceutical Contract Development and Manufacturing
Table 47. Key Industry Trends of Pharmaceutical Contract Development and Manufacturing
Table 48. Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermo Fisher Scientific Inc. Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
Table 54. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermo Fisher Scientific Inc. Main Business
Table 56. Thermo Fisher Scientific Inc. Latest Developments
Table 57. Catalent, Inc. Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 58. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
Table 59. Catalent, Inc. Main Business
Table 60. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Catalent, Inc. Latest Developments
Table 62. Lonza Group Ltd Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 63. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Offered
Table 64. Lonza Group Ltd Main Business
Table 65. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Lonza Group Ltd Latest Developments
Table 67. Recipharm AB Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 68. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Offered
Table 69. Recipharm AB Main Business
Table 70. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Recipharm AB Latest Developments
Table 72. Vetter Pharma International GMBH Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 73. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Offered
Table 74. Vetter Pharma International GMBH Main Business
Table 75. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Vetter Pharma International GMBH Latest Developments
Table 77. FAMAR Health Care Services Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 78. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Offered
Table 79. FAMAR Health Care Services Main Business
Table 80. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. FAMAR Health Care Services Latest Developments
Table 82. AbbVie Inc. Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 83. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Offered
Table 84. AbbVie Inc. Main Business
Table 85. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AbbVie Inc. Latest Developments
Table 87. Aenova Group Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 88. Aenova Group Pharmaceutical Contract Development and Manufacturing Product Offered
Table 89. Aenova Group Main Business
Table 90. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Aenova Group Latest Developments
Table 92. Consort Medical plc Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 93. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Offered
Table 94. Consort Medical plc Main Business
Table 95. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Consort Medical plc Latest Developments
Table 97. Almac Group Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 98. Almac Group Pharmaceutical Contract Development and Manufacturing Product Offered
Table 99. Almac Group Main Business
Table 100. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Almac Group Latest Developments
Table 102. Siegfried Holding AG Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 103. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Offered
Table 104. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Siegfried Holding AG Main Business
Table 106. Siegfried Holding AG Latest Developments
Table 107. Boehringer Ingelheim International GmbH Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 108. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Offered
Table 109. Boehringer Ingelheim International GmbH Main Business
Table 110. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Boehringer Ingelheim International GmbH Latest Developments
Table 112. Evonik Industries AG Details, Company Type, Pharmaceutical Contract Development and Manufacturing Area Served and Its Competitors
Table 113. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Offered
Table 114. Evonik Industries AG Main Business
Table 115. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Evonik Industries AG Latest Developments

LIST OF FIGURES

Figure 1. Pharmaceutical Contract Development and Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pharmaceutical Contract Development and Manufacturing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pharmaceutical Contract Development and Manufacturing Sales Market Share by Country/Region (2022)
Figure 8. Pharmaceutical Contract Development and Manufacturing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type in 2022
Figure 10. Pharmaceutical Contract Development and Manufacturing in Big Pharma
Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market: Big Pharma (2018-2023) & ($ Millions)
Figure 12. Pharmaceutical Contract Development and Manufacturing in Small Pharma
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market: Small Pharma (2018-2023) & ($ Millions)
Figure 14. Pharmaceutical Contract Development and Manufacturing in Generic Pharma
Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market: Generic Pharma (2018-2023) & ($ Millions)
Figure 16. Pharmaceutical Contract Development and Manufacturing in CRO
Figure 17. Global Pharmaceutical Contract Development and Manufacturing Market: CRO (2018-2023) & ($ Millions)
Figure 18. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application in 2022
Figure 19. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Player in 2022
Figure 20. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Pharmaceutical Contract Development and Manufacturing Market Size 2018-2023 ($ Millions)
Figure 22. APAC Pharmaceutical Contract Development and Manufacturing Market Size 2018-2023 ($ Millions)
Figure 23. Europe Pharmaceutical Contract Development and Manufacturing Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size 2018-2023 ($ Millions)
Figure 25. Americas Pharmaceutical Contract Development and Manufacturing Value Market Share by Country in 2022
Figure 26. United States Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Region in 2022
Figure 31. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type in 2022
Figure 32. APAC Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application in 2022
Figure 33. China Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Country in 2022
Figure 40. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Figure 41. Europe Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Figure 42. Germany Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Pharmaceutical Contract Development and Manufacturing Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 56. APAC Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 57. Europe Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 59. United States Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 60. Canada Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 63. China Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 64. Japan Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 65. Korea Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 67. India Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 68. Australia Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 69. Germany Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 70. France Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 71. UK Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 72. Italy Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 73. Russia Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 74. Spain Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 77. Israel Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Pharmaceutical Contract Development and Manufacturing Market Size 2024-2029 ($ Millions)
Figure 80. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share Forecast by Application (2024-2029)


More Publications